comparemela.com
Home
Live Updates
Kyverna Therapeutics Closes $85 Million Series B Financing l
Kyverna Therapeutics Closes $85 Million Series B Financing l
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
/PRNewswire/ -- Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced...
Related Keywords
Brian Kotzin ,
Biopartners Westlake ,
Iconovir Bio ,
Chris Liu ,
Fred Cohen ,
Danielk Spiegelman ,
Mark Genovese ,
Ian Clark ,
Dominic Borie ,
Desmond Padhi ,
Beth Seidenberg ,
Heba Nowyhed ,
Ishaan Gandhi ,
Gilead Sciences ,
Gilead Company ,
Genentech ,
Nektar Therapeutics ,
National Institutes Of Health ,
Tizona Therapeutics Inc ,
Rigel Pharmaceuticals ,
Westlake Village Biopartners ,
Vida Ventures ,
Insight Partners ,
Intellia Therapeutics ,
Argentum Peak ,
Hudson Bay Capital ,
National Institutes ,
Regt Cell ,
Northpond Ventures ,
Tizona Therapeutics ,
Myriad Genetics ,
Spruce Biosciences ,
Kyverna Therapeutics ,